A detailed history of Citigroup Inc transactions in Eyenovia, Inc. stock. As of the latest transaction made, Citigroup Inc holds 407 shares of EYEN stock, worth $32. This represents 0.0% of its overall portfolio holdings.

Number of Shares
407
Previous 4,931 91.75%
Holding current value
$32
Previous $2,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$0.46 - $1.44 $2,081 - $6,514
-4,524 Reduced 91.75%
407 $0
Q2 2024

Aug 12, 2024

SELL
$0.52 - $1.06 $207 - $422
-399 Reduced 7.49%
4,931 $2,000
Q1 2024

May 10, 2024

SELL
$0.99 - $2.37 $149 - $357
-151 Reduced 2.75%
5,330 $5,000
Q4 2023

Feb 09, 2024

BUY
$1.08 - $2.08 $5,823 - $11,215
5,392 Added 6058.43%
5,481 $11,000
Q3 2023

Nov 09, 2023

SELL
$1.57 - $2.54 $12,864 - $20,812
-8,194 Reduced 98.93%
89 $0
Q2 2023

Aug 10, 2023

BUY
$2.21 - $5.75 $18,305 - $47,627
8,283 New
8,283 $19,000

Others Institutions Holding EYEN

About EYENOVIA, INC.


  • Ticker EYEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,212,900
  • Market Cap $2.74M
  • Description
  • Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...
More about EYEN
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.